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1. Introduction 
Recent studies have revealed that glucose 1,6- 
diphosphate (Glc-1,6-P,), which was first shown by 
Leloir et al. [l--31 to be the coenzyme in the phos- 
pho~ucomutase r action, acts as a potent regulator 
common to several key enzymes in carbohydrate 
metabo~sm. The levels of this regulator were found 
to be strikingly reduced in muscle from genetically 
dystrophic mice [4,5]. Since Glc-1 ,6-P2 is one of the 
strongest activators (deinhibitors) of phosphofructo- 
kinase [6-81, the rate-limiting enzyme in glycolysis, 
the reduction in Glc-I ,6-P* levels in the dystrophic 
muscle could offer an explanation for the observed 
reduction in the allosteric activity of phosphofructo- 
kinase and glycolysis in the dystrophic muscle [4]. 
Our results have also revealed that the decrease in
Glc-1,6-P, in dystrophic muscle may be attributed 
to the increase in the activity of Glc-1,6-P, phos- 
phatase (the enzyme which degradates Glc-1,6-P,) 
[9]. Based on our experiments which have shown that 
the Glc-1 ,6-P2 levels in muscle change under various 
physiological nd hormonal conditions [ 10-131, we 
investigated the effect of fasting and refeeding on the 
levels of this regulator in muscle of normal and 
dystrophic mice, and examined whether the changes 
in Glc-1 ,6-PZ induced by these conditions are asso- 
ciated with concomitant changes in the activities of 
phosphofructo~ase and phospho~ucomutase. We
also investigated the changes in Glc-1,6-P, phos- 
phatase activity under these conditions. 
The results here show. that the decrease in Glc-1,6- 
Pa and the concomitant reduction in the activities of 
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phosphofructokinase and phosphoglucomutase 
which occur in muscular dystrophy, can be reversed 
by the fasting-refeeding treatment, which reduces 
Glc-1,6-P, phosphatase activity to normal evel. 
2. Methods 
Normal and genetically dystrophic mice of strain 
129 ReJ, aged 4-7 weeks, were used. The animals 
were divided into three groups: fed ad libitum, fasted 
for 22 h, or fasted for 22 h and then refed for 9 h. 
Mice were anesthetized with 60 mg/kg sodium pento- 
barbital, hind-leg muscles were removed and rapidly 
frozen between apair of aluminium tongs precooled 
in liquid NZ. Frozen muscles were powdered in a 
mortar cooled in liquid Nz, and the powder was used 
for extraction of Glc-1,6-P, and enzymes. 
Glc-1 ,6-PZ was extracted and measured as in [5]. 
Phosphofructo~a~ was extracted and assayed 
spectrophotometrically at pH 6.9 (regulatory condi- 
tions) and at pH 8.2 (maximal, non-regulatory con- 
ditions) as in [4,13]. 1 munit of phosphofructokinase 
activity catalyzed the formation of 1 nmol fru-1,6-P, 
per min at 25’C. Phosphoglucomutase nd Glc-1,6- 
PZ phosphatase were extracted in 10 volumes of 
0.02 M Tris-HCl @H 7.0) and the homogenate was 
centrifuged at 4’C for 10 min at 27 000 X g. Glc- 
1,6-P, phosphatase was assayed as in [9]. 1 munit of 
Glc-1 ,6-PZ phosphatase activity catalyzed the degra- 
dation of 1 nmol of Glc-1,6-P, per 15 min at 37°C. 
~ospho~ucomutase was assayed spectrophoto- 
metrically measuring both regulatory and maximal 
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activity as in [ 131.1 munit of phospho~u~muta~ 
activity catalyzed the reduction of 1 nmol of NADP’/ 
mm at 25°C. Protein was measured by the method in 
[14]. Non-collagen protein was determined by the 
method in [15]. 
3. Results 
As shown in fig.1, the levels of Glc-1,6-P, in 
muscle of normal mice were markedly reduced after 
22 h of fasting. When the fasted normal mice were 
refed for 9 h, the Glc-1,6-P, returned to initial levels. 
In muscle of dystrophic mice, where the Glc-1 ,6-PZ 
levels were much lower than normal, 22 h fasting 
induced a proportionally similar eduction in Glc- 
1 ,6-PZ. However, when the fasted dystrophic mice 
were refed, the Glc-1 ,6-PZ levels were not only 
restored to the initial dystrophic level, but dramati- 
cally reached the levels of the normal muscle. 
Since Glc-1,6-P, is a potent activator of phospho- 
fructokinase and phospho~u~omutase, in the experi- 
ments demonstrated in tables 1 and 2, we examined 
whether a correlation exists between the striking 
changes in Glc-1,6-P, during fasting and refeeding 
and the activities of these enzymes. As can be seen 
from table 1, phosphofructokinase activity, when 
measured under regulatory conditions (i.e., when the 
enzyme is subject o regulation by Glc-1,6-P* and its 
other allosteric effecters [ 13 ,16-19]), was in fulI 
correlation to Glc-1,6-P, levels (fig.1). It was reduced 
by fasting and increased by refeeding. (The changes in 
the enzyme’s activity under all conditions, were 
similar, whether the results were expressed per mg 
protein or per mg noncollagen protein.) In the 
dystrophic muscle, where the enzyme activity was 
significantly lower than normal, there was a propor- 
tionally similar esponse to fasting, but a strikingly 
greater sensitivity to refeeding; phosphofructokinase 
activity was almost completely restored to normal 
values, in muscle of the refed dystrophic mice. Phos- 
phofructokinase activity was also measured at pH 8.2, 
under conditions known to be optimal for its activity, 
where the enzyme shows no regulatory (allosteric) 
properties [13,16-191. Under these maxhnal condi- 
tions, there was no significant difference in phos- 






Fed Fasted Refed 
Fig.1. The effect of fasting and refeeding on Glc-1,6-P, 
levels in muscle of normal and dystrophic mice. Values are 
means f SEM for 5 -10 animals in each group. P values 
(fasted VS. fed; refed vs. fasted; dystrophic fed vs. normal fed) 
<o.oos. 
mice, whether fed, fasted or refed. Similar esults 
were obtained for phospho~ucomutase ctivity 
(table 2). The regulatory activity, measured under 
subrn~~ con~tions, where the enzyme is sensitive 
to activation by Glc-1,6-P, [13] correlated with the 
intracellular changes of Glc-1,6-P, (fgl); it was sig- 
nificantly lower in the dystrophic muscle, and was 
reduced by fasting and increased by refeeding both in 
the normal and dystrophic muscle. Similar to phos- 
phofructokinase, the maximal activity of this enzyme 
(measured under optimal conditions, and in the 
presence of saturating concentration of Glc-1,6-P, 
[13]) did not change through all the different experi- 
mental states. 
Trying to unde~t~d the interesting changes in 
Glc-1,6-P,, induced by fasting and refeeding of both 
normal and dystrophic mice (fig.l), we measured the 
activity of Glc-1,6-P, phosphatase (the enzyme that 
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Table 1 
The effect of fasting and refeeding on phosphofructokinase activity in normal and 
dystrophic muscle 
Phosphofructokinase activity 
Regulatory activity Maximal activity 
-. 
mU/mg protein mU/mg NCPa mU/mg protein mU/mg NCPa 
Norma1 
Fed 230 t 12 283 r 20 802 f. 23 987 * 29 
Fasted 118tlO 153 * 11 149 f 14 918* 12 
Refed 287 r 24 369 f 33 740 f 54 987 * 69 
Dysfmphic 
Fed 6’32 5 81+ 6 706 4 15 918 + 84 
Fasted 27~ 3 35* 3 641 f 95 812 f 96 
Refed 162 i: 11 223 f 21 671 k: 36 923 f 37 
a NCP, non-collagen protein 
Values are means f SEM for 6-10 animals in each group 
P values: regulatory activity (fasted vs. fed; refed vs. fasted; dystrophic fed vs. normal 
fed) <0.005; maximal activity, not significant 
degradates Glc-l ,6-P,). Table 3 shows marked 
increase in Glc-1,6-P, phosphatase activity in the 
dystrophic muscle. Fasting induced an elevation in 
the enzyme’s activity in both normal and dystrophic 
mice and refeeding reduced its activity. In the refed 
dystrophic mice there was a most dramatic decrease 
in Glc-1 ,6-P, phosphatase activity, falling to the 
levels of a normal fed mouse. 
Table 2 
The effect of fasting and refeeding on the activity of phosphoglucomutase in normal 
and dystrophic muscle 
Phospho~ucomuta~ activity 
Regulatory activity Maximal activity 
mU/mg protein mU/mg NCPa mU/mg protein mU/mg NCPa 
Normal 
Fed 256 f 13 315 f 20 2350* 81 2830 i 130 
Fasted 87* 9 129 * 16 2350 i 100 2870 f 100 
Refed 280 i 14 371*17 2300 f 70 2870 i 150 
Dysfrophic 
Fed 132 1: 20 169 * 30 2266 i 348 2750 ? 443 
Fasted 88* 11 111 * 16 2178 f 228 2650 f 320 
Refed 177 f 20 227 i 27 2157 f 90 2600 i 112 
a NCP, non-collagen protein 
Values are mean i SEM for 6 -10 animals in each group 
P values: regulatory activity {fasted vs. fed; refed vs. fasted; dystrophic fed vs. normal 
fed) <0.002; maximal activity, not significant 
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Table 3 
The influence of fasting and refeeding on the activity of 
Glc-1,6-P, phosphatase in normal and dystrophic muscle 
Glc-1,6-P, phosphatase activity 
mU/mg protein mU/mg NCPa 
Normal 
Fed 0.30 f 0.01 
Fasted 0.45 f 0.04 
Refed 0.21 f 0.01 
Dystrophic 
Fed 0.66 f 0.01 
Fasted 0.89 +_ 0.01 
Refed 0.29 f 0.05 
a NCP, non-collagen protein 
0.36 i 0.02 
0.53 f 0.05 
0.28 f 0.01 
0.84 f 0.05 
1.02 f 0.04 
0.37 f 0.05 
Values are means f SEM for 6-10 animals in each group 
P values (fasted vs. fed; refed vs. fasted; dystrophic fed vs. 
normal fed) <0.005 
4. Discussion 
The results presented in this paper eveal a striking 
correlation between the tissue levels of Glc-1 ,6Pz 
and the activities of phosphofructokinase and phos- 
phoglucomutase which are activated by this regulator. 
Fasting induced a reduction in Glc-1 ,6PZ and a con- 
comitant reduction in the activities of both enzymes 
in normal and dystrophic muscle, whereas refeeding 
induced a rise in Glc-1 ,6-P2 accompanied by an 
enhancement in these enzymes’ activities. The close 
correlation between intracellular levels of Glc-1 ,6-PZ 
and the enzymes’ activities was also found in our 
earlier studies under various other physiological nd 
hormonal conditions [10,12,13]. The results trongly 
suggest that the changes in phosphofructokinase and 
phosphoglucomutase ctivities induced by fasting and 
refeeding are mediated by changes in the intracellular 
concentration of the regulator, and are not due to 
changes in the total content of these enzymes in the 
cell. This suggestion isbased on the fact that the 
changes in enzymes’ activities were demonstrated 
only when assayed under regulatory (submaximal) 
conditions (which most probably represent the native 
state of the enzymes in muscle cell [18,20,21], 
whereas their maximal activities, namely, their full 
catalytic potential, remained unchanged (tables 1,2). 
It is interesting that the dystrophic muscle is much 
more sensitive to refeeding than the normal muscle. 
Refeeding of the fasted dystrophic mice results in an 
overshooting of Glc-1 ,6-PZ and a concomitant rise in 
the activities of phosphofructokinase and phospho- 
glucomutase , reaching values of the normal control 
mice. These results uggest that refeeding may reverse 
the reduction in glycolytic capacity of the dystrophic 
muscle, by raising the concentration of Glc-1 ,6-P2. 
Since the activity of Glc-1 ,6-PZ phosphatase, which 
rises markedly in the dystrophic muscle, is dramati- 
cally reduced to normal evels in the refed dystrophic 
mice (table 3), it offers an explanation to the mecha- 
nism by which Glc-1,6-P, rises so strikingly following 
refeeding (fig.1). The factor responsible for inhibition 
of this enzyme’s activity during refeeding is at present 
under investigation i our laboratory. 
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